Over the past month, CL has declined by 6.3%, and year-to-date, it’s down 14.24%. The 52-week range is $77.09 to $102.61, indicating the stock is near its yearly low.
Key Financials:
Market Cap: $63.01 billion
Revenue (TTM): $20.00 billion
Net Income (TTM): $2.91 billion
EPS (TTM): $3.56
P/E Ratio: 21.90
Forward P/E: 20.76
Dividend Yield: 2.67% ($2.08 annually, ex-dividend date Oct 17, 2025)
Beta: 0.34 (low volatility)
Analyst Outlook: Analysts rate CL as a "Moderate Buy" with a consensus price target of $93.50, suggesting a potential upside of 19.93%. Price targets range from $80 to $108. Recent analyst actions include downgrades (e.g., Wells Fargo maintaining a "Sell" rating at $80) and upgrades (e.g., Citigroup and UBS with "Strong Buy" ratings at $10
Key Financials:
Market Cap: $63.01 billion
Revenue (TTM): $20.00 billion
Net Income (TTM): $2.91 billion
EPS (TTM): $3.56
P/E Ratio: 21.90
Forward P/E: 20.76
Dividend Yield: 2.67% ($2.08 annually, ex-dividend date Oct 17, 2025)
Beta: 0.34 (low volatility)
Analyst Outlook: Analysts rate CL as a "Moderate Buy" with a consensus price target of $93.50, suggesting a potential upside of 19.93%. Price targets range from $80 to $108. Recent analyst actions include downgrades (e.g., Wells Fargo maintaining a "Sell" rating at $80) and upgrades (e.g., Citigroup and UBS with "Strong Buy" ratings at $10
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.